ADMS - Adamas Pharmace Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 AAPL (%) BABA (%) LZB (%) MYOV (%) V (%) DGAZ (%) NVDA (%) SPY (-0.17%) UGAZ (%) AVGR (%) ATNM (%) AMRN (1.26%) HIIQ (-8.79%) GS (%) GOOGL (%) GOOG (%) GDX (%) FCEL (-2.04%) FB (%) ETHUSD (%) ETCUSD (%) ENG (1%) DIS (%) DHR (0.14%) DASHUSD (%)

ADMS - Adamas Pharmaceutica...

$5.47 0.15[2.82%]

15 mins delayed data

People also watch : ABBV | SUPN | ZGNX | CBIO | GSK | MRK

+Watchlist

4 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$5.32	Open	$5.30
Volume	176.9K	Market Cap	126.93M
Yield		Last Dividend

Day

52 Week

Adamas to Present at Upcoming Evercore I...	1:02 PM
EMERYVILLE, Calif., Nov. 21, 2019 -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent ...

Edited Transcript of ADMS earnings confe...	11/19/19
Q3 2019 Adamas Pharmaceuticals Inc Earnings Call

Adamas Announces New Employment Induceme...	11/08/19
Adamas Pharmaceuticals, Inc. (ADMS) today announced that the compensation committee of the company’s board of directors granted three new employees th...

The Daily Biotech Pulse: Therapix Calls ...	11/08/19
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs N...

Adamas Pharmaceuticals (ADMS) Reports Q3...	11/07/19
Adamas (ADMS) delivered earnings and revenue surprises of -10.00% and -2.97%, respectively, for the quarter ended September 2019. Do the numbers hold ...

Adamas Reports Third Quarter 2019 Financ...	11/07/19
- Third quarter GOCOVRI® product sales of $13.9 million; total prescriptions grew to approximately 6,640 - Topline results from INROADS Phase 3 study ...

What's in the Offing for Humana'...	11/04/19
Humana's (HUM) third-quarter results are likely to reflect rise in expenses and a negative impact from seasonality on its bottom line.

ANALYST RATINGS

1 analyst ratings (Last 6 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

Hold rating	09/09/19
Cantor Fitzgerald initiates coverage with Neutral rating and announces Price Target of $8.00

EARNINGS

Date	2019-11-07 (AMC)	Est. (EPS/Rev.)	($0.89)/ 14.07M
Actual (EPS/Rev.)	$-0.99/ $13.93 M	EPS (TTM)	0

TRADERS TRACKING $ADMS

Service Name	Trader	% Success
Alpha Swing Trades	Jonathan	69.00 %	Follow
Biotechnology	Robert Gadimian	26.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.